# LifeStance Health Group Inc. (LFST) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Health Care Equipment & Supplies. Price $12.73, market value $4.9 billion.

## Valuation
- **P/E (trailing): 97.9×**. LifeStance Health Group Inc. trades at 97.9× trailing earnings. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 24.0×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 3.1×**. Each dollar of revenue is priced at 3.1×.
- **Price / book: 3.3×**. The shares trade at 3.3× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 40.5×**. Enterprise value is 40.5× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Free-cash-flow yield: 3.6%**. Free cash flow equals 3.6% of the market value.
- **Earnings yield: 1.0%**. The inverse of the P/E: 1.0% of the price is earned each year.

## Profitability
- **Operating margin: 4.9%**. 4.9% of revenue is left after running the business, which leaves little cushion in a downturn.
- **Net margin: 0.7%**. 0.7% of each dollar of sales reaches the bottom line.
- **Return on equity: 0.6%**. 0.6% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 4.0%**. Return on all capital, debt included, is 4.0%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: 2.3%**. Each dollar of assets produces 2.3% of profit.

## Growth
- **Revenue growth (1 yr): 13.9%** (3-yr 18.3%/yr, 5-yr 46.3%/yr). Revenue grew 13.9% over the last year, against 46.3% a year compounded over five years: growth is slowing.

## Financial health
- **Debt to equity: 0.18**. Debt is 0.18 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 0.3×**. It would take 0.3 years of operating earnings to repay net borrowings, within the comfortable range.
- **Altman Z-score: 5.92**. A Z-score of 5.92 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. LifeStance Health Group Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (10 analysts). 10 analysts cover LifeStance Health Group Inc.; the consensus is buy, with an average price target of $13.80 (+8% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 132.7%** (YTD 80.8%, 3-mo 71.8%). The shares are up 132.7% over twelve months including dividends.
- **From 52-week high: -3.2%** (166.9% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 63**. An RSI of 63 is neutral.
- **Beta (1 yr): 0.72** (volatility 54%). Beta of 0.72 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=LFST · Page: https://foliofundamentals.com/stocks/lfst

Not investment advice.